{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:53:32Z","timestamp":1791852812838,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":98,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203447"],"award-info":[{"award-number":["82203447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"1\u00b73\u00b75 Project for Disciplines of Excellence, West China Hospital","award":["ZYGD23017"],"award-info":[{"award-number":["ZYGD23017"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1103702"],"award-info":[{"award-number":["2022YFA1103702"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02723-5","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:07:49Z","timestamp":1783418869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting HASPIN-mediated H3T3 phosphorylation disrupts an epigenetic-kinesin axis to suppress colorectal cancer mitotic progression"],"prefix":"10.1186","volume":"25","author":[{"given":"Tong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chensong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuye","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"2723_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233\u201354. https:\/\/doi.org\/10.3322\/caac.21772.","journal-title":"CA Cancer J Clin"},{"key":"2723_CR2","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1097\/CM9.0000000000001076","volume":"133","author":"Y Yang","year":"2020","unstructured":"Yang Y, et al. Current status of surgical treatment of rectal cancer in China. Chin Med J (Engl). 2020;133:2703\u201311. https:\/\/doi.org\/10.1097\/CM9.0000000000001076.","journal-title":"Chin Med J (Engl)"},{"key":"2723_CR3","doi-asserted-by":"publisher","first-page":"e70127","DOI":"10.1002\/mco2.70127","volume":"6","author":"J Li","year":"2025","unstructured":"Li J, Pan J, Wang L, Ji G, Dang Y. Colorectal Cancer: Pathogenesis and Targeted Therapy. MedComm (2020). 2025;6:e70127. https:\/\/doi.org\/10.1002\/mco2.70127.","journal-title":"MedComm (2020)"},{"key":"2723_CR4","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394:1467\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(19)32319-0.","journal-title":"Lancet"},{"key":"2723_CR5","doi-asserted-by":"publisher","unstructured":"Zhan T, et al. Digestive cancers: mechanisms, therapeutics and management. Signal Transduct Target Ther. 2025;10. https:\/\/doi.org\/10.1038\/s41392-024-02097-4.","DOI":"10.1038\/s41392-024-02097-4"},{"key":"2723_CR6","doi-asserted-by":"publisher","unstructured":"Haynes J, Manogaran P. Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer. Int J Mol Sci. 2025;26. https:\/\/doi.org\/10.3390\/ijms26051988.","DOI":"10.3390\/ijms26051988"},{"key":"2723_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.gde.2018.09.001","volume":"52","author":"N Sasaki","year":"2018","unstructured":"Sasaki N, Clevers H. Studying cellular heterogeneity and drug sensitivity in colorectal cancer using organoid technology. Curr Opin Genet Dev. 2018;52:117\u201322. https:\/\/doi.org\/10.1016\/j.gde.2018.09.001.","journal-title":"Curr Opin Genet Dev"},{"key":"2723_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12943-025-02281-2","volume":"24","author":"Z Peng","year":"2025","unstructured":"Peng Z, Lv X, Sun H, Zhao L, Huang. 3D tumor cultures for drug resistance and screening development in clinical applications. Mol Cancer. 2025;24:93. https:\/\/doi.org\/10.1186\/s12943-025-02281-2.","journal-title":"Mol Cancer"},{"key":"2723_CR9","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1002\/mco2.495","volume":"5","author":"M Gu","year":"2024","unstructured":"Gu M, et al. Epigenetic regulation in cancer. MedComm (2020). 2024;5:e495. https:\/\/doi.org\/10.1002\/mco2.495.","journal-title":"MedComm (2020)"},{"key":"2723_CR10","doi-asserted-by":"publisher","unstructured":"Zhang Y, Zhang Q, Zhang Y, Han J. The Role of Histone Modification in DNA Replication-Coupled Nucleosome Assembly and Cancer. Int J Mol Sci. 2023;24. https:\/\/doi.org\/10.3390\/ijms24054939.","DOI":"10.3390\/ijms24054939"},{"key":"2723_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/17501911.2024.2430169","volume":"17","author":"R Vatapalli","year":"2025","unstructured":"Vatapalli R, Rossi AP, Chan HM, Zhang J. Cancer epigenetic therapy: recent advances, challenges, and emerging opportunities. Epigenomics. 2025;17:59\u201374. https:\/\/doi.org\/10.1080\/17501911.2024.2430169.","journal-title":"Epigenomics"},{"key":"2723_CR12","first-page":"2989","volume":"33","author":"A Gnyszka","year":"2013","unstructured":"Gnyszka A, Jastrzebski Z, Flis S. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer. Anticancer Res. 2013;33:2989\u201396.","journal-title":"Anticancer Res"},{"key":"2723_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.21.595243","author":"CW Hicks","year":"2024","unstructured":"Hicks CW, et al. Haspin kinase binds to a nucleosomal DNA supergroove. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.05.21.595243.","journal-title":"bioRxiv"},{"key":"2723_CR14","doi-asserted-by":"publisher","unstructured":"Hadders MA, et al. Untangling the contribution of Haspin and Bub1 to Aurora B function during mitosis. J Cell Biol. 2020;219. https:\/\/doi.org\/10.1083\/jcb.201907087.","DOI":"10.1083\/jcb.201907087"},{"key":"2723_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.cub.2017.02.019","volume":"27","author":"L Zhou","year":"2017","unstructured":"Zhou L, et al. The N-Terminal Non-Kinase-Domain-Mediated Binding of Haspin to Pds5B Protects Centromeric Cohesion in Mitosis. Curr Biol. 2017;27:992\u20131004. https:\/\/doi.org\/10.1016\/j.cub.2017.02.019.","journal-title":"Curr Biol"},{"key":"2723_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.15252\/embr.201744737","volume":"19","author":"C Liang","year":"2018","unstructured":"Liang C, et al. A kinase-dependent role for Haspin in antagonizing Wapl and protecting mitotic centromere cohesion. EMBO Rep. 2018;19:43\u201356. https:\/\/doi.org\/10.15252\/embr.201744737.","journal-title":"EMBO Rep"},{"key":"2723_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/jclinpath-2020-206956","volume":"74","author":"H Medani","year":"2021","unstructured":"Medani H, Elshiekh M, Naresh K. N. Improving precise counting of mitotic cells in mantle cell lymphoma using phosphohistone H3 (PHH3) antibody. J Clin Pathol. 2021;74:646\u20139. https:\/\/doi.org\/10.1136\/jclinpath-2020-206956.","journal-title":"J Clin Pathol"},{"key":"2723_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/PAI.0000000000000499","volume":"26","author":"I Elmaci","year":"2018","unstructured":"Elmaci I, Altinoz MA, Sari R, Bolukbasi FH. Phosphorylated Histone H3 (PHH3) as a Novel Cell Proliferation Marker and Prognosticator for Meningeal Tumors: A Short Review. Appl Immunohistochem Mol Morphol. 2018;26:627\u201331. https:\/\/doi.org\/10.1097\/PAI.0000000000000499.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2723_CR19","doi-asserted-by":"publisher","first-page":"115289","DOI":"10.1016\/j.bcp.2022.115289","volume":"206","author":"CI Lin","year":"2022","unstructured":"Lin CI, et al. Co-inhibition of Aurora A and Haspin kinases enhances survivin blockage and p53 induction for mitotic catastrophe and apoptosis in human colorectal cancer. Biochem Pharmacol. 2022;206:115289. https:\/\/doi.org\/10.1016\/j.bcp.2022.115289.","journal-title":"Biochem Pharmacol"},{"key":"2723_CR20","doi-asserted-by":"publisher","first-page":"101627","DOI":"10.1016\/j.xcrm.2024.101627","volume":"5","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, et al. Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer. Cell Rep Med. 2024;5:101627. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101627.","journal-title":"Cell Rep Med"},{"key":"2723_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/procel\/pwad038","volume":"15","author":"Y Mao","year":"2024","unstructured":"Mao Y, et al. Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids. Protein Cell. 2024;15:285\u2013304. https:\/\/doi.org\/10.1093\/procel\/pwad038.","journal-title":"Protein Cell"},{"key":"2723_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1021\/ml200259q","volume":"3","author":"M Haddach","year":"2012","unstructured":"Haddach M, et al. Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor. ACS Med Chem Lett. 2012;3:135\u20139. https:\/\/doi.org\/10.1021\/ml200259q.","journal-title":"ACS Med Chem Lett"},{"key":"2723_CR23","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1158\/0008-5472.CAN-19-2330","volume":"80","author":"JC Melms","year":"2020","unstructured":"Melms JC, et al. Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity. Cancer Res. 2020;80:798\u2013810. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-2330.","journal-title":"Cancer Res"},{"key":"2723_CR24","doi-asserted-by":"publisher","first-page":"111605","DOI":"10.1016\/j.yexcr.2019.111605","volume":"385","author":"X Han","year":"2019","unstructured":"Han X, et al. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo. Exp Cell Res. 2019;385:111605. https:\/\/doi.org\/10.1016\/j.yexcr.2019.111605.","journal-title":"Exp Cell Res"},{"key":"2723_CR25","doi-asserted-by":"publisher","first-page":"111863","DOI":"10.1016\/j.yexcr.2020.111863","volume":"390","author":"D Zhu","year":"2020","unstructured":"Zhu D, et al. HASPIN is involved in the progression of gallbladder carcinoma. Exp Cell Res. 2020;390:111863. https:\/\/doi.org\/10.1016\/j.yexcr.2020.111863.","journal-title":"Exp Cell Res"},{"key":"2723_CR26","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1007\/s00432-022-04260-2","volume":"149","author":"C Geng","year":"2023","unstructured":"Geng C, et al. Effects and mechanisms of GSG2 in esophageal cancer progression. J Cancer Res Clin Oncol. 2023;149:3409\u201321. https:\/\/doi.org\/10.1007\/s00432-022-04260-2.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2723_CR27","doi-asserted-by":"publisher","first-page":"8858","DOI":"10.18632\/aging.103005","volume":"12","author":"Y Chen","year":"2020","unstructured":"Chen Y, Fu D, Zhao H, Cheng W, Xu F. GSG2 (Haspin) promotes development and progression of bladder cancer through targeting KIF15 (Kinase-12). Aging. 2020;12:8858\u201379. https:\/\/doi.org\/10.18632\/aging.103005.","journal-title":"Aging"},{"key":"2723_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3892\/ijo.2020.5043","volume":"57","author":"F Yu","year":"2020","unstructured":"Yu F, et al. Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo. Int J Oncol. 2020;57:139\u201350. https:\/\/doi.org\/10.3892\/ijo.2020.5043.","journal-title":"Int J Oncol"},{"key":"2723_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1089\/gtmb.2020.0298","volume":"26","author":"W Yu","year":"2022","unstructured":"Yu W, Liu W, Feng Y, Zhu C. Knockdown of GSG2 Suppresses the Progression of Colorectal Cancer Cells. Genet Test Mol Biomarkers. 2022;26:26\u201336. https:\/\/doi.org\/10.1089\/gtmb.2020.0298.","journal-title":"Genet Test Mol Biomarkers"},{"key":"2723_CR30","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/ncb3210","volume":"17","author":"H Liu","year":"2015","unstructured":"Liu H, et al. Redeployment of Myc and E2f1-3 drives Rb-deficient cell cycles. Nat Cell Biol. 2015;17:1036\u201348. https:\/\/doi.org\/10.1038\/ncb3210.","journal-title":"Nat Cell Biol"},{"key":"2723_CR31","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrc3556","volume":"13","author":"S Sadasivam","year":"2013","unstructured":"Sadasivam S, DeCaprio JA. The DREAM complex: master coordinator of cell cycle-dependent gene expression. Nat Rev Cancer. 2013;13:585\u201395. https:\/\/doi.org\/10.1038\/nrc3556.","journal-title":"Nat Rev Cancer"},{"key":"2723_CR32","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1038\/sj.emboj.7600459","volume":"23","author":"W Zhu","year":"2004","unstructured":"Zhu W, Giangrande PH, Nevins JR. E2Fs link the control of G1\/S and G2\/M transcription. EMBO J. 2004;23:4615\u201326. https:\/\/doi.org\/10.1038\/sj.emboj.7600459.","journal-title":"EMBO J"},{"key":"2723_CR33","doi-asserted-by":"publisher","unstructured":"Etchegaray JP et al. The Histone Deacetylase SIRT6 Restrains Transcription Elongation via Promoter-Proximal Pausing. Mol Cell. 2019;75:683\u2013699 e687. https:\/\/doi.org\/10.1016\/j.molcel.2019.06.034.","DOI":"10.1016\/j.molcel.2019.06.034"},{"key":"2723_CR34","doi-asserted-by":"publisher","first-page":"1745087","DOI":"10.3389\/fphar.2025.1745087","volume":"16","author":"A Szczepaniak","year":"2025","unstructured":"Szczepaniak A, Jaskula K, Zielinska M, Godlewski J. Transcriptional rewiring in cancer driven by POLR2A\/RPB1: mechanistic insights, non-coding RNA crosstalk, and therapeutic opportunities. Front Pharmacol. 2025;16:1745087. https:\/\/doi.org\/10.3389\/fphar.2025.1745087.","journal-title":"Front Pharmacol"},{"key":"2723_CR35","doi-asserted-by":"publisher","unstructured":"Yang X, Tong Y, Ye W, Chen L. HOXB2 increases the proliferation and invasiveness of colon cancer cells through the upregulation of CCT6A. Mol Med Rep. 2022;25. https:\/\/doi.org\/10.3892\/mmr.2022.12690.","DOI":"10.3892\/mmr.2022.12690"},{"key":"2723_CR36","doi-asserted-by":"publisher","first-page":"e83373","DOI":"10.1371\/journal.pone.0083373","volume":"8","author":"YH Xin","year":"2013","unstructured":"Xin YH, et al. POU5F1 enhances the invasiveness of cancer stem-like cells in lung adenocarcinoma by upregulation of MMP-2 expression. PLoS ONE. 2013;8:e83373. https:\/\/doi.org\/10.1371\/journal.pone.0083373.","journal-title":"PLoS ONE"},{"key":"2723_CR37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/gb-2003-4-2-206","volume":"4","author":"J Kaczynski","year":"2003","unstructured":"Kaczynski J, Cook T, Urrutia R. Sp1- and Kruppel-like transcription factors. Genome Biol. 2003;4:206. https:\/\/doi.org\/10.1186\/gb-2003-4-2-206.","journal-title":"Genome Biol"},{"key":"2723_CR38","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/onc.2011.335","volume":"31","author":"D Huertas","year":"2012","unstructured":"Huertas D, et al. Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin. Oncogene. 2012;31:1408\u201318. https:\/\/doi.org\/10.1038\/onc.2011.335.","journal-title":"Oncogene"},{"key":"2723_CR39","doi-asserted-by":"publisher","first-page":"18404","DOI":"10.1039\/d1cp02783b","volume":"23","author":"Q Wang","year":"2021","unstructured":"Wang Q, Zhang Q, Leung ELH, Chen Y, Yao X. Exploring the thermodynamic, kinetic and inhibitory mechanisms of 5-iTU targeting mitotic kinase haspin by integrated molecular dynamics. Phys Chem Chem Phys. 2021;23:18404\u201313. https:\/\/doi.org\/10.1039\/d1cp02783b.","journal-title":"Phys Chem Chem Phys"},{"key":"2723_CR40","doi-asserted-by":"publisher","first-page":"118135","DOI":"10.1016\/j.biopha.2025.118135","volume":"188","author":"YZ Shin","year":"2025","unstructured":"Shin YZ, et al. Targeting HASPIN in gemcitabine-resistant pancreatic cancer cells by lead optimization of thioadenosine analogue. Biomed Pharmacother. 2025;188:118135. https:\/\/doi.org\/10.1016\/j.biopha.2025.118135.","journal-title":"Biomed Pharmacother"},{"key":"2723_CR41","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1002\/jcp.29328","volume":"235","author":"P Wang","year":"2020","unstructured":"Wang P, et al. Haspin inhibition delays cell cycle progression through interphase in cancer cells. J Cell Physiol. 2020;235:4508\u201319. https:\/\/doi.org\/10.1002\/jcp.29328.","journal-title":"J Cell Physiol"},{"key":"2723_CR42","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/jpp\/rgac080","volume":"75","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Function and inhibition of Haspin kinase: targeting multiple cancer therapies by antimitosis. J Pharm Pharmacol. 2023;75:445\u201365. https:\/\/doi.org\/10.1093\/jpp\/rgac080.","journal-title":"J Pharm Pharmacol"},{"key":"2723_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/cac2.12125","volume":"41","author":"A Chen","year":"2021","unstructured":"Chen A, et al. CRISPR\/Cas9 screening identifies a kinetochore-microtubule dependent mechanism for Aurora-A inhibitor resistance in breast cancer. Cancer Commun (Lond). 2021;41:121\u201339. https:\/\/doi.org\/10.1002\/cac2.12125.","journal-title":"Cancer Commun (Lond)"},{"key":"2723_CR44","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/annonc\/mdh264","volume":"15","author":"P Noordhuis","year":"2004","unstructured":"Noordhuis P, et al. 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers. Ann Oncol. 2004;15:1025\u201332. https:\/\/doi.org\/10.1093\/annonc\/mdh264.","journal-title":"Ann Oncol"},{"key":"2723_CR45","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1126\/science.1189435","volume":"330","author":"F Wang","year":"2010","unstructured":"Wang F, et al. Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis. Science. 2010;330:231\u20135. https:\/\/doi.org\/10.1126\/science.1189435.","journal-title":"Science"},{"key":"2723_CR46","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11427-022-2167-3","volume":"66","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, et al. Trim28 citrullination maintains mouse embryonic stem cell pluripotency via regulating Nanog and Klf4 transcription. Sci China Life Sci. 2023;66:545\u201362. https:\/\/doi.org\/10.1007\/s11427-022-2167-3.","journal-title":"Sci China Life Sci"},{"key":"2723_CR47","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/s41388-024-02991-9","volume":"43","author":"Q Xiong","year":"2024","unstructured":"Xiong Q, et al. tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c\u2013MYC transcription. Oncogene. 2024;43:1274\u201387. https:\/\/doi.org\/10.1038\/s41388-024-02991-9.","journal-title":"Oncogene"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02723-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02723-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02723-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:43:54Z","timestamp":1791852234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02723-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2723"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02723-5","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"4 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments using specimens were approved by the ethics committee and performed strictly abiding by relevant regulations of the Declaration of Helsinki under the prerequisite of obtaining written informed consent, and approved by the Ethics Committee of West China Hospital, Sichuan University (Chengdu, China, IRB number 2023\u2009\u2212\u20091501). All animal procedures were approved by the local Institutional Animal Care and Use Committee (Approval number:20250611006).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"238"}}